Robert Nelsen - Insider Trading & Ownership

Entity
Individual
Location
8755 W. Higgins Road, Suite 1025, Chicago, IL
Summary
The estimated net worth of Robert Nelsen is at least $432M dollars as of June 17, 2024. Robert Nelsen is the Director of Denali Therapeutics Inc. and owns shares of Denali Therapeutics Inc. (DNLI) stock worth about $178M. Robert Nelsen is the Director, 10%+ Owner of Prime Medicine, Inc. and owns shares of Prime Medicine, Inc. (PRME) stock worth about $96.7M. Robert Nelsen is the Director, 10%+ Owner of Lyell Immunopharma, Inc. and owns shares of Lyell Immunopharma, Inc. (LYEL) stock worth about $83M. Robert Nelsen is the Director, 10%+ Owner of Sana Biotechnology, Inc. and owns shares of Sana Biotechnology, Inc. (SANA) stock worth about $68.5M. Robert Nelsen is the Director of Vir Biotechnology, Inc. and owns shares of Vir Biotechnology, Inc. (VIR) stock worth about $5.87M.
All Insider Reports
All Insider Reports

Ownership of Robert Nelsen

Insider Transactions Reported by Robert Nelsen:

* An asterisk sign (*) next to the price indicates that the price is likely invalid.